H3 Biomedicine Inc., a start-up focused on cancer treatments based on genetics, officially unveiled its new office in Cambridge yesterday. Todd R. Golub, HMS professor of pediatrics at the Dana-Farber Cancer Institute, is one of the scientific founders of the company.
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure